ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RYZB RayzeBio Inc

62.49
0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
RayzeBio Inc RYZB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 62.49 19:00:00
Open Price Low Price High Price Close Price Previous Close
62.49 62.49
more quote information »

Recent News

Date Time Source Heading
3/07/202415:07EDGAR2Form 15-12G - Securities registration termination [Section..
2/27/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202408:20EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/26/202408:20EDGAR2Form 8-K - Current report
2/23/202406:53EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2/23/202405:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
2/14/202408:19EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2/12/202407:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2/12/202405:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
2/06/202417:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202407:53EDGAR2Form SC 14D9 - Solicitation, recommendation statements
1/08/202409:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
12/27/202315:15EDGAR2Form SC14D9C - Written communication relating to third party..
12/26/202316:08EDGAR2Form SC14D9C - Written communication relating to third party..
12/26/202309:28DJNTrending: Bristol Myers Squibb to Buy RayzeBio
12/26/202307:32EDGAR2Form SC14D9C - Written communication relating to third party..
12/26/202307:26EDGAR2Form 8-K - Current report
12/26/202307:04DJNRayzeBio Shares Soar Premarket on Takeover by Bristol Myers
12/26/202306:46DJNBristol Myers Squibb to Buy RayzeBio for $4.1 Billion
12/26/202306:13GLOBEBristol Myers Squibb Adds Premier Radiopharmaceutical..
12/26/202305:59BW Bristol Myers Squibb Adds Premier Radiopharmaceutical..
11/17/202317:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:03EDGAR2Form 8-K - Current report
11/13/202315:01GLOBERayzeBio Reports Third Quarter 2023 Financial Results and..
11/06/202315:05GLOBERayzeBio to Participate in Upcoming Investor Conferences in..
11/01/202308:14EDGAR2Form 8-K - Current report
11/01/202305:00GLOBERayzeBio Appoints Industry Leader Tim Van Hauwermeiren to..
10/24/202307:00GLOBEFDA selects RayzeBio to Participate in the Inaugural CDRP..
10/18/202306:00GLOBERayzeBio to Present at European Society for Medical Oncology..
9/19/202315:01BWRayzeBio, Inc. Announces Closing of Upsized $358 Million..